Xyrion Medical Institute

Xyrion Medical Institute is a private biomedical research center and consulting firm based in Ponce, Puerto Rico, specializing in clinical development and regenerative medicine. The institute is primarily focused on metabolic health, inflammation, and age management, having conducted significant research in collaboration with pharmaceutical partners such as Tersus Pharmaceuticals and institutions like the Cleveland Clinic. It is notably recognized for leading the first human randomized controlled trial of Provinal (purified palmitoleic acid) for cardiometabolic indications. Beyond its clinical research services, Xyrion provides strategic consulting for life science companies and offers expertise in advanced therapies, including stem cell and peptide-based treatments. Although a major study on its lead candidate was retracted in 2021 due to data concerns, the institute continues to operate as an active participant in the Puerto Rican clinical research ecosystem.